Factors affecting relative dose intensity in patients with Hodgkin lymphoma (HL) receiving doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) without granulocyte-colony stimulating factor (G-CSF) support

被引：0
|
作者：
Kirui, L. C. [1 ]
Cwynarski, K. [1 ]
McNamara, C. [1 ]
机构：
[1] Royal Free Hosp, Dept Haematol, London NW3 2QG, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 157卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
135
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [31] ECONOMIC MODEL OF GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) IN PRIMARY (PP) AND SECONDARY PROPHYLAXIS (SP) OF FEBRILE NEUTROPENIA (FN) IN NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS UNDERGOING CHEMOTHERAPY IN FRANCE
    Perrier, L.
    Sebban, C.
    Leon, N.
    Maurel, F.
    Cohen-Nizard, S.
    De Liege, F.
    VALUE IN HEALTH, 2011, 14 (07) : A450 - A450
  • [32] Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L)
    Bruserud, O
    Foss, B
    Petersen, H
    EUROPEAN CYTOKINE NETWORK, 2001, 12 (02) : 231 - 238
  • [33] Patterns of mortality after prolonged follow-up of a randomized trial using granulocyte colony-stimulating factor (G-CSF) to maintain chemotherapy dose intensity in non-Hodgkin lymphoma (NHL).
    Clamp, A. R.
    Bhattacharya, S.
    Ryder, D. W.
    Pettengell, R.
    Radford, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 444S - 444S
  • [34] MITOXANTRONE PLUS VINORELBINE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) SUPPORT IN ADVANCED BREAST-CANCER PATIENTS - A DOSE AND SCHEDULE FINDING STUDY
    FRASCI, G
    COMELLA, G
    COMELLA, P
    SALZANO, F
    CREMONE, L
    DELLAVOLPE, N
    IMBRIANI, A
    PERSICO, G
    BREAST CANCER RESEARCH AND TREATMENT, 1995, 35 (02) : 147 - 156
  • [35] A retrospective review of primary prophylaxis with granulocyte-colony stimulating factor (G-CSF) for patients with genitourinary malignancies receiving chemotherapy during the COVID-19 pandemic and implications for the future.
    Mejia, Nely Mercy Diaz
    Stecca, Carlos
    Jiang, Di Maria
    Fallah-Rad, Nazanin
    Bedard, Philippe L.
    Kumar, Vikaash
    Abdeljalil, Osama
    Zahralliyali, Amer
    Alqaisi, Husam
    Al-Ezzi, Esmail Mutahar
    Choy, Vivian
    Banwait, Parmvir
    Atenafu, Eshetu
    Sridhar, Srikala S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [36] Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study
    Kim, Jin Seok
    Yoon, Dok Hyun
    Park, Seonyang
    Yoon, Sung-Soo
    Cho, Seok-Goo
    Min, Chang-Ki
    Lee, Je-Jung
    Yang, Deok-Hwan
    Kwak, Jae-Yong
    Eom, Hyeon-Seok
    Kim, Won Seog
    Kim, Hawk
    Do, Young Rok
    Moon, Joon Ho
    Lee, Jihye
    Suh, Cheolwon
    ANNALS OF HEMATOLOGY, 2016, 95 (04) : 603 - 611
  • [37] Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study
    Jin Seok Kim
    Dok Hyun Yoon
    Seonyang Park
    Sung-Soo Yoon
    Seok-Goo Cho
    Chang-Ki Min
    Je-Jung Lee
    Deok-Hwan Yang
    Jae-Yong Kwak
    Hyeon-Seok Eom
    Won Seog Kim
    Hawk Kim
    Young Rok Do
    Joon Ho Moon
    Jihye Lee
    Cheolwon Suh
    Annals of Hematology, 2016, 95 : 603 - 611
  • [38] THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin's lymphoma in elderly patients: a prospective study
    Niitsu, N
    Umeda, M
    LEUKEMIA, 1997, 11 (11) : 1817 - 1820
  • [39] THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin’s lymphoma in elderly patients: a prospective study
    N Niitsu
    M Umeda
    Leukemia, 1997, 11 : 1817 - 1820
  • [40] EFFECT OF CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF A SMALL DOSE OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) BY THE USE OF A PORTABLE INFUSION-PUMP IN PATIENTS WITH NON-HODGKINS-LYMPHOMA RECEIVING CHEMOTHERAPY
    FURUYA, H
    WAKAYAMA, T
    OHGUNI, S
    YAMAUCHI, K
    TANAKA, J
    HATAZOE, T
    KATO, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1995, 61 (03) : 123 - 129
12345